Janssen Liability Increased to $1.6 Billion in Drug Fraud Suit
Janssen Products LP must pay over $1.6 billion in a False Claims Act suit for improperly billing the US government for HIV ...
Johnson & Johnson unit ordered to pay $1.64 billion in HIV drug marketing case
A federal judge ordered a Johnson & Johnson unit on Friday to pay the U.S. government $1.64 billion after a jury found it ...
Ulcerative Colitis Treatment Market 2034: EMA, PDMA, FDA Approvals, Clinical trials, Medication, Therapies, Prevalence and Companies by DelveInsight
Ulcerative Colitis companies are Janssen Pharmaceuticals, Takeda Pharmaceuticals, Pfizer, EA Pharma, Kissei Pharma, Gilead ...
JNJ Unit Ordered to Cough Up $1.64B for Illegal Promotion of HIV Drugs
A unit of medical group Johnson & Johnson (JNJ) has been ordered to pay $1.64 billion for illegally promoting the HIV drugs Prezista and ...
FMIBlog12d
Global Extended Release Drugs Market Poised for Significant Growth CAGR of 11% through 2032 | FMI
The global extended release drugs market is experiencing significant growth, projected to expand at a robust 11% CAGR from 2022 to 2032. With a valuation of USD 48 billion in 2022, the market is ...